Editorial Staff

Study Applauds State Decision To Let Healthcare Spending Benchmark Decrease

/in , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Calls on policy makers to continue pursuing efforts to trim healthcare spending

BOSTON – A new Pioneer Institute Policy Brief applauds the decision by the Commonwealth’s Health Policy Commission to allow the benchmark for increases in the overall rate of healthcare spending to decrease this year, but urges state policy makers to remain focused on the larger culture changes that will be needed to rein in healthcare costs.

Download: Lowering the Healthcare Cost Growth Benchmark

“It’s important to keep our cost control expectations high,” said Pioneer Senior Fellow in Healthcare Barbara Anthony, who coauthored “Lowering the Healthcare Cost Growth Benchmark” with Scott Haller.  “But we must stay focused on the larger factors that drive healthcare costs.”

Haller and Anthony urge the commonwealth to carefully study the performance of providers and payers in terms of their adoption of payment reform measures, such as of alternative payment methodologies (APMs), and to continue to pursue other approaches to reducing costs such as providing consumers with incentives to use lower-cost, high-quality providers. “The impetus behind Ch. 224 was that payment reform would bring about efficiencies and cost savings. It’s time to ask providers and payers: Where’s the beef?” Anthony added.

Traditional fee-for-service payment arrangements offer incentives for providers to increase profits by conducting more tests and other medical procedures.

Chapter 224 of the Acts of 2012 was designed to control healthcare costs by encouraging the adoption of payment reform measures under which providers assume some or all of the financial risk associated with providing health care services and are rewarded for quality outcomes.  Since the provider assumes financial risk, there is an incentive to hold costs down while striving for good patient results.  Transparency provisions that make it easier for consumers to access cost and quality information were designed to ensure that quality is maintained.

Through last year, the spending benchmark included in Chapter 224 was pegged to the projected annual growth in gross state product (GSP), which has been forecast at 3.6 percent since 2013.  At 2.4 percent, growth in consumer healthcare spending was below benchmark in 2013, but it rose to 4.2 percent and 4.1 percent respectively in 2014 and 2015.

This year the benchmark was slated to drop to half a percentage point below projected GSP growth.  The Health Policy Commission could have delayed the decrease, but it chose not to do so.

About the Authors:

Barbara Anthony, a lawyer, is a senior fellow in healthcare at Pioneer Institute focusing on healthcare price and quality transparency.  She is also an associate at the Harvard Kennedy School’s Center for Business and Government.  She served as Massachusetts Undersecretary for Consumer Affairs and Business Regulation from 2009 to 2015.

Scott Haller graduated from Northeastern University with a Bachelor’s Degree in Political Science. He started working at Pioneer Institute through the Northeastern’s Co-op Program and continues now as the Lovett C. Peters Fellow in Healthcare. He previously worked at the Office of the Inspector General.

Pioneer Institute is an independent, non-partisan, privately funded research organization that seeks to improve the quality of life in Massachusetts through civic discourse and intellectually rigorous, data-driven public policy solutions based on free market principles, individual liberty and responsibility, and the ideal of effective, limited and accountable government.

Get Updates On Our Healthcare Cost Transparency Initiative!

Pioneer Institute: 340B Hospitals Does Not Necessarily Translate to Charity Care

Review of Becker’s List of Health Systems with Strong Finances…

Average Weekly Wages of Healthcare Workers Across a Decade

From 2012-22 the healthcare and social assistance sector has seen the smallest growth in average weekly wages of any large industry in Massachusetts. This potentially has dire consequences on the employment crisis that this industry already faces.

An Evaluation of 340B in Massachusetts

Despite the fact that the 340B Drug Pricing Program has expanded immensely in recent years, the amount of charity care that hospitals are providing has decreased. This points to several problems with the 340B program across the country and in Massachusetts, such as a lack of transparency and inaccessible care.

Do No Harm to the Health Policy Commission

With only weeks left in the Massachusetts legislative calendar,…

New Online Tool Tracks MA Hospital Revenue from Commercial Sources

A new online tool from Pioneer Institute shows a gradual increase in non-commercial (public payer) revenue at Massachusetts hospitals and also reveals a strong relationship between the hospitals with the highest commercial revenue and those with the highest relative prices.

Middlemen Pushing Up Retail Costs of Drugs

The reality is that non-price factors, including several players, are causing net prices to decline and retail prices to increase. Those players include employers, health plans, and pharmacy benefit managers (PBMs), all of whom have continuously circumvented the system through loopholes and complicated systems of reimbursement that tend to hurt patients

Study: Massachusetts Should Join 45 States and Allow Prescribers to Dispense Medications

A Pioneer Institute study shows that middlemen—commercial pharmacies and pharmacy benefit managers—add substantial costs over wholesale prices. Allowing prescribers to dispense routine drugs would save consumers money without compromising safety.

Survey Finds Spotty Compliance Among Hospitals with Federal Price Transparency Law

A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.

Healthcare dominates the job market.

0 Comments
/
Healthcare and social assistance are among the most important…

Caution towards CMS Data Sources for Healthcare Legislation

0 Comments
/
Policymakers rely on accurate and timely data when implementing legislation or regulation to address biopharmaceutical spending in the U.S. Based on this research, policymakers may want to utilize other sources in addition to NHE data provided by CMS when making policy recommendations. 
This file is licensed under the Creative Commons Attribution 2.0 Generic license.

Healthcare Employs More on Cape Cod Than Any Other Sector

0 Comments
/
Despite being a major tourist destination, the largest employment sector on Cape Cod is not related to tourism: it is healthcare!

How did COVID impact Massachusetts’ long-term care facilities?

Pioneer Institute has filed a Public Records Act request related to COVID's impact on Massachusetts’ long-term care facilities because the Institute believes this is a matter of obvious importance, both on principle (the public has a right to know the facts), and for purposes of evaluating – and where possible improving – public policy. 

Pioneer Institute Statement on the Commonwealth’s Discontinuance of the COVID-19 Weekly Public Health Report

Useful information about COVID cases or deaths at individual homes has become less available at a time when cases are increasing again, even among vaccinated residents. Pioneer urges Massachusetts to immediately reinstate the so-called Weekly Report, which contains cases and deaths inside individual nursing homes.

Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Study Calls for Better Reporting on Impact of COVID-19 in Eldercare Facilities

Over time, the Massachusetts Executive Office of Health and Human Services and Department of Public Health (DPH) have improved reporting about cases and deaths from COVID-19 in state-regulated eldercare facilities, but flaws and omissions remain and should be corrected, according to a new study published by Pioneer Institute.